UTAH MEDICAL PRODUCTS INC UTMD revenue by segment, product and geography
In its fiscal year ending 2025-12-31, UTAH MEDICAL PRODUCTS INC reported revenue across 2 geographies; the largest, Global, was $38.5M (-5.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Global$38.5Mshare n/a-5.8% yoy
- Ous$15.8Mshare n/a-9.7% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Gynecology Electrosurgery Urology$5.23M59.9%no prior
- Neonatal$1.57M18.0%no prior
- Blood Pressure Monitoring And Accessories$1.02M11.7%no prior
- Obstetrics$905K10.4%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.